Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder.
Randomized Controlled Trial of Omega-3 and -6 Fatty Acid Supplementation to Reduce Inflammatory Markers in Children with Autism Spectrum Disorder.
复制标题
DOI:
10.1007/s10803-021-05396-9
复制
发表时间:
2022-12
影响因子:
3.9
通讯作者:
Rogers, Lynette K.
中科院分区:
文献类型:
--
作者:
Keim, Sarah A.;Jude, Abigail;Smith, Katie;Khan, Aiman Q.;Coury, Daniel L.;Rausch, Joseph;Udaipuria, Shivika;Norris, Megan;Bartram, Lindsay R.;Narayanan, Anita R.;Rogers, Lynette K.
This double-blind, randomized controlled trial, tested fatty acid (FA) supplementation in children (ages 2−<6 years) recently diagnosed with Autism Spectrum Disorder (ASD). Participants received daily oral FA supplement containing omega-3 and omega-6 FA, or a placebo for 90 days based on participant weight. Erythrocyte FAs and the cytokines, IL-1β, IL-2, IFNγ, were measured in plasma obtained from serial blood collections. Treatment increased omega-3 and omega-6 FA levels (1.40 mol% for EPA and 1.62 mol% for DHA) and reduced IL-2 levels compared to placebo (−0.17 pg/mL, 95% CI: −0.31, −0.02, d=−0.62). Omega 3-6 treatment was tolerable and adherence was greater than 70%. Future research will assess the effects of Omega 3-6 treatment on ASD symptoms. Registered on 06/08/2018 with ClinicalTrials.gov: NCT03550209.
登录
查看更多内容
DOI:
10.1073/pnas.042698699
发表时间:
2002-03-05
影响因子:
11.1
作者:
Kitajka, K;Puskás, LG;Farkas, T
通讯作者:
Farkas, T
DOI:
10.1176/appi.ps.202000099
发表时间:
2021-01-01
期刊:
Psychiatric services (Washington, D.C.)
影响因子:
--
作者:
Grosse SD;Ji X;Nichols P;Zuvekas SH;Rice CE;Yeargin-Allsopp M
通讯作者:
Yeargin-Allsopp M
DOI:
10.1111/apa.15858
发表时间:
2021-07
期刊:
Acta paediatrica (Oslo, Norway : 1992)
影响因子:
--
作者:
通讯作者:
--
影响因子:
3.9
作者:
Bent, Stephen;Bertoglio, Kiah;Ashwood, Paul;Bostrom, Alan;Hendren, Robert L.
通讯作者:
Hendren, Robert L.
影响因子:
3.7
作者:
Christian, Lisa M.;Young, Andrea S.;Fristad, Mary A.
通讯作者:
Fristad, Mary A.